Safe Pain Management in Pregnant Patients

Safe pain management for pregnant patients poses a unique clinical challenge due to physiological changes, fetal considerations, and ethical constraints on pharmacological intervention. Whether in the postoperative period or managing chronic non-operative pain, pregnant patients require tailored strategies that prioritize parental comfort and fetal safety. Since certain analgesics can cross the placenta, clinicians must carefully select medications to minimize teratogenic or developmental risks. This is especially important during the first trimester, when fetal organogenesis is underway. Acetaminophen is the most widely accepted first-line analgesic due to its favorable safety profile across all trimesters. However, evidence has shown that long-term or high-dose exposure may be linked to neurodevelopmental outcomes, though causality remains debated (1).

Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective in the management of moderate to severe pain but are generally contraindicated for pregnant patients in the third trimester due to the risk of premature closure of the fetal ductus arteriosus and oligohydramnios. They may be cautiously used in the second trimester for short durations when the benefits outweigh the potential risks. Although opioids are occasionally necessary for acute postoperative pain, such as after cesarean sections or emergency surgeries, they carry concerns of neonatal respiratory depression, physical dependence, and long-term behavioral effects. Their use must be judicious and time-limited, with careful monitoring (2).

The growing emphasis on multimodal analgesia has shifted clinical practices away from overreliance on systemic drugs. Regional anesthesia, including epidurals and nerve blocks, is often used for labor and postoperative cesarean pain management. This approach provides targeted pain relief with minimal fetal exposure. For instance, transcutaneous electrical nerve stimulation (TENS) and low-level laser therapy have demonstrated potential in alleviating postoperative pain following cesarean sections without causing any known adverse fetal effects (3).

Pain related to surgical emergencies, including rare conditions such as intestinal obstruction or intra-abdominal hemorrhage, highlights the importance of prompt diagnosis and safe analgesic strategies. In a recent case of small bowel obstruction during the third trimester, for example, clinicians effectively managed preoperative and postoperative pain using non-opioid analgesics and supportive modalities, thus avoiding the fetal risks associated with systemic opioids (1).

Special considerations are also necessary for pain management in pregnant patients experiencing chronic conditions, such as musculoskeletal or neuropathic pain. For example, pregnant patients experiencing pelvic girdle pain may benefit from physiotherapy, warm compresses, or acupuncture. Medications such as gabapentin or antidepressants are generally avoided unless essential due to limited safety data. Clinicians must also address the psychological aspects of pain because untreated anxiety or depression can worsen pain perception. In select cases, collaborative psychological care has been associated with improved outcomes and decreased reliance on analgesics (4).

Ultimately, safe pain management in pregnant patients involves balancing minimizing fetal exposure to harmful substances with ensuring parental well-being. The evidence supports a stepwise approach: first, non-pharmacological strategies; then, pharmacological therapies with known safety profiles; and, as a last resort, more potent analgesics under close supervision. Achieving this delicate balance is essential for improving parental and neonatal outcomes.

References

1. Syed SA, Latif F, Rafique A, Anwar A. Intestinal Obstruction in the Third Trimester of Pregnancy: Maternal and Fetal Outcomes. Cureus. 2025;17(5):e84980. Published 2025 May 28. doi:10.7759/cureus.84980
2. De Vicari D, Barba M, Cola A, Frigerio M. Managing Urethral Diverticulum During Pregnancy Utilizing Advanced Ultrasonographic Techniques: A Literature Review and Case Study. Biomedicines. 2025;13(6):1432. Published 2025 Jun 11. doi:10.3390/biomedicines13061432
3. de Miranda Silva Nogueira PA, Almeida CS, Silva IA, et al. TENS alone or combined with low-level laser therapy photobiomodulation for pain, functional capacity, and cardiorespiratory physiological variables after cesarean section: protocol for a randomized clinical trial. PLoS One. 2025;20(6):e0325254. doi:10.1371/journal.pone.0325254Liu B, Ling L, Wei D, et al. Predictive models for intrapartum maternal fever: Development and validation of pre-analgesia and labor process indicators. Medicine (Baltimore). 2025;104(25):e42939. doi:10.1097/MD.0000000000042939